Published in Am J Respir Crit Care Med on October 17, 2008
Subclinical atherosclerotic vascular disease in chronic obstructive pulmonary disease: Prospective hospital-based case control study. Lung India (2015) 1.21
Subclinical atherosclerosis, airflow obstruction and emphysema: the MESA Lung Study. Eur Respir J (2011) 1.11
The relationship between small pulmonary vascular alteration and aortic atherosclerosis in chronic obstructive pulmonary disease: quantitative CT analysis. Acad Radiol (2010) 1.07
The association between COPD and heart failure risk: a review. Int J Chron Obstruct Pulmon Dis (2013) 1.06
Lack of association of ischemic heart disease with COPD when taking into account classical cardiovascular risk factors. Int J Chron Obstruct Pulmon Dis (2010) 1.02
Potential mechanisms linking atherosclerosis and increased cardiovascular risk in COPD: focus on Sirtuins. Int J Mol Sci (2013) 1.00
Activation of the TLR4 signaling pathway and abnormal cholesterol efflux lead to emphysema in ApoE-deficient mice. Am J Physiol Lung Cell Mol Physiol (2012) 0.96
Emphysema is associated with increased inflammation in lungs of atherosclerosis-prone mice by cigarette smoke: implications in comorbidities of COPD. J Inflamm (Lond) (2010) 0.94
The role of microparticles in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis (2014) 0.89
Retrospective analysis of the relationship between decline in FEV(1) and abdominal circumference in male smokers: the Takahata study. Int J Med Sci (2012) 0.88
Role of endothelin receptor A and NADPH oxidase in vascular abnormalities. Vasc Health Risk Manag (2010) 0.86
A lower level of forced expiratory volume in 1 second is a risk factor for all-cause and cardiovascular mortality in a Japanese population: the Takahata study. PLoS One (2013) 0.81
Cross-sectional and prospective study of the association between lung function and prediabetes. BMJ Open (2013) 0.80
Epicardial adipose tissue in patients with chronic obstructive pulmonary disease. PLoS One (2013) 0.80
C-reactive protein levels, airflow obstruction, and chronic kidney disease. Environ Health Prev Med (2011) 0.80
Metabolic syndrome and carotid intima-media thickness in chronic obstructive pulmonary disease. Multidiscip Respir Med (2013) 0.79
Relationship Among Chlamydia and Mycoplasma Pneumoniae Seropositivity, IKZF1 Genotype and Chronic Obstructive Pulmonary Disease in A General Japanese Population: The Nagahama Study. Medicine (Baltimore) (2016) 0.77
Differences in serum SP-D levels between German and Japanese subjects are associated with SFTPD gene polymorphisms. BMC Med Genet (2014) 0.77
Increased brachial intima-media thickness is associated with circulating levels of asymmetric dimethylarginine in patients with COPD. Int J Chron Obstruct Pulmon Dis (2017) 0.75
COPD in smokers with atherosclerosis: are we missing the trail? Am J Respir Crit Care Med (2009) 0.75
Systemic and Pulmonary Vascular Remodelling in Chronic Obstructive Pulmonary Disease. PLoS One (2016) 0.75
GDF-15 plasma levels in chronic obstructive pulmonary disease are associated with subclinical coronary artery disease. Respir Res (2017) 0.75
Heart-lung interaction via infection. Ann Am Thorac Soc (2014) 0.75
Pulmonary function and CT biomarkers as risk factors for cardiovascular events in male lung cancer screening participants: the NELSON study. Eur Radiol (2014) 0.75
Subclinical Carotid Atherosclerosis in COPD Cases and Control Smokers: Analysis in Relation with COPD Exacerbations and Exacerbation-like Episodes. Lung (2017) 0.75
Relation between respiratory function and arterial stiffness assessed using brachial-ankle pulse wave velocity in healthy workers. J Phys Ther Sci (2017) 0.75
Characterization of noncalcified coronary plaques and identification of culprit lesions in patients with acute coronary syndrome by 64-slice computed tomography. JACC Cardiovasc Imaging (2009) 2.20
Different MUC1 gene polymorphisms in German and Japanese ethnicities affect serum KL-6 levels. Respir Med (2012) 2.12
Significance of bronchoalveolar lavage for the diagnosis of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (2009) 1.88
Comparative study of KL-6, surfactant protein-A, surfactant protein-D, and monocyte chemoattractant protein-1 as serum markers for interstitial lung diseases. Am J Respir Crit Care Med (2002) 1.84
Elevation of KL-6, a lung epithelial cell marker, in plasma and epithelial lining fluid in acute respiratory distress syndrome. Am J Physiol Lung Cell Mol Physiol (2003) 1.82
Angiotensin II induces thrombospondin-1 production in human mesangial cells via p38 MAPK and JNK: a mechanism for activation of latent TGF-beta1. Am J Physiol Renal Physiol (2003) 1.79
Consensus statement for the diagnosis and treatment of drug-induced lung injuries. Respir Investig (2013) 1.70
Dikkopf-1 as a novel serologic and prognostic biomarker for lung and esophageal carcinomas. Cancer Res (2007) 1.68
PPAR-gamma agonist attenuates renal interstitial fibrosis and inflammation through reduction of TGF-beta. Lab Invest (2008) 1.68
Prospective versus retrospective ECG-gated 64-detector coronary CT angiography: assessment of image quality, stenosis, and radiation dose. Radiology (2008) 1.65
Pulse wave velocity predicts cardiovascular mortality: findings from the Hawaii-Los Angeles-Hiroshima study. Circ J (2005) 1.62
Diffuse alveolar hemorrhage associated with lenalidomide. Int J Hematol (2011) 1.61
White blood cell count, especially neutrophil count, as a predictor of hypertension in a Japanese population. Hypertens Res (2008) 1.54
Successful treatment of imatinib-resistant hypereosinophilic syndrome with nilotinib. Leuk Res (2010) 1.53
Clarithromycin-induced eosinophilic pneumonia. Intern Med (2004) 1.52
Anti-Ku antibody-positive scleroderma-dermatomyositis overlap syndrome developing Graves' disease and immune thrombocytopenic purpura. Intern Med (2002) 1.49
Production of eosinophilic chemokines by normal pleural mesothelial cells. Am J Respir Cell Mol Biol (2002) 1.46
Neutropenic enterocolitis in lung cancer: a report of two cases and a review of the literature. Intern Med (2005) 1.45
Decreased total and high molecular weight adiponectin are independent risk factors for the development of type 2 diabetes in Japanese-Americans. J Clin Endocrinol Metab (2006) 1.43
Identification of nectin-4 oncoprotein as a diagnostic and therapeutic target for lung cancer. Cancer Res (2009) 1.42
Effect of glucose polymer on the intercellular junctions of cultured human peritoneal mesothelial cells. Nephron Clin Pract (2003) 1.42
Visceral fat accumulation as a predictor of coronary artery calcium as assessed by multislice computed tomography in Japanese patients. Atherosclerosis (2008) 1.42
Cancer-testis antigen lymphocyte antigen 6 complex locus K is a serologic biomarker and a therapeutic target for lung and esophageal carcinomas. Cancer Res (2007) 1.42
Aminopeptidase N is involved in cell motility and angiogenesis: its clinical significance in human colon cancer. Gastroenterology (2002) 1.39
Gene expression profiles of small-cell lung cancers: molecular signatures of lung cancer. Int J Oncol (2006) 1.38
Prognostic value of circulating KL-6 in idiopathic pulmonary fibrosis. Respirology (2006) 1.37
Prediction of sensitivity of advanced non-small cell lung cancers to gefitinib (Iressa, ZD1839). Hum Mol Genet (2004) 1.35
Paramyxovirus Sendai virus-like particle formation by expression of multiple viral proteins and acceleration of its release by C protein. Virology (2004) 1.34
DEC1 modulates the circadian phase of clock gene expression. Mol Cell Biol (2008) 1.31
Wnt inhibitor Dickkopf-1 as a target for passive cancer immunotherapy. Cancer Res (2010) 1.31
Utility of KL-6/MUC1 in the clinical management of interstitial lung diseases. Respir Investig (2012) 1.29
Low heart rate variability is a risk factor for sudden cardiac death in type 2 diabetes. Diabetes Res Clin Pract (2004) 1.28
Increased plasma ghrelin level in lung cancer cachexia. Clin Cancer Res (2003) 1.27
Erlotinib efficacy and cerebrospinal fluid concentration in patients with lung adenocarcinoma developing leptomeningeal metastases during gefitinib therapy. Cancer Chemother Pharmacol (2011) 1.24
Inducible lung-specific urokinase expression reduces fibrosis and mortality after lung injury in mice. Am J Physiol Lung Cell Mol Physiol (2002) 1.24
Increases of amphiregulin and transforming growth factor-alpha in serum as predictors of poor response to gefitinib among patients with advanced non-small cell lung cancers. Cancer Res (2005) 1.24
Suppression of plasminogen activator inhibitor-1 by RNA interference attenuates pulmonary fibrosis. Thorax (2010) 1.23
ANLN plays a critical role in human lung carcinogenesis through the activation of RHOA and by involvement in the phosphoinositide 3-kinase/AKT pathway. Cancer Res (2005) 1.22
A-kinase anchoring protein AKAP220 binds to glycogen synthase kinase-3beta (GSK-3beta ) and mediates protein kinase A-dependent inhibition of GSK-3beta. J Biol Chem (2002) 1.22
Inferior mesenteric arteriovenous fistula eight years after sigmoidectomy. Intern Med (2002) 1.19
Elevated C-reactive protein is a risk factor for the development of type 2 diabetes in Japanese Americans. Diabetes Care (2003) 1.18
Plakophilin 3 oncogene as prognostic marker and therapeutic target for lung cancer. Cancer Res (2005) 1.18
A novel human tRNA-dihydrouridine synthase involved in pulmonary carcinogenesis. Cancer Res (2005) 1.16
Reduction in fibrotic tissue formation in mice genetically deficient in plasminogen activator inhibitor-1. Am J Pathol (2003) 1.15
Association between visceral adipose tissue area and coronary plaque morphology assessed by CT angiography. JACC Cardiovasc Imaging (2010) 1.13
Westernization of lifestyle markedly increases carotid intima-media wall thickness (IMT) in Japanese people. Atherosclerosis (2003) 1.12
Polymorphisms in the thymidylate synthase and methylenetetrahydrofolate reductase genes and sensitivity to the low-dose methotrexate therapy in patients with rheumatoid arthritis. Int J Mol Med (2003) 1.12
Activation of CDCA1-KNTC2, members of centromere protein complex, involved in pulmonary carcinogenesis. Cancer Res (2006) 1.12
Identification of Epstein-Barr virus-induced gene 3 as a novel serum and tissue biomarker and a therapeutic target for lung cancer. Clin Cancer Res (2011) 1.11
ADAM8 as a novel serological and histochemical marker for lung cancer. Clin Cancer Res (2004) 1.10
Elevated plasma ghrelin level in underweight patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2004) 1.10
Role of osteoprotegerin in arterial calcification: development of new animal model. Arterioscler Thromb Vasc Biol (2007) 1.09
MS-275, a novel histone deacetylase inhibitor with selectivity against HDAC1, induces degradation of FLT3 via inhibition of chaperone function of heat shock protein 90 in AML cells. Leuk Res (2008) 1.08
Telomerase expression in noncancerous bronchial epithelia is a possible marker of early development of lung cancer. Cancer Res (2005) 1.08
Signal transducer and activator of transcription 3 involvement in the development of renal interstitial fibrosis after unilateral ureteral obstruction. Nephrology (Carlton) (2007) 1.08
Circulating visfatin level is correlated with inflammation, but not with insulin resistance. Clin Endocrinol (Oxf) (2007) 1.08
Novel orthotopic implantation model of human malignant pleural mesothelioma (EHMES-10 cells) highly expressing vascular endothelial growth factor and its receptor. Cancer Sci (2006) 1.05
Analysis of Aurora B kinase in non-Hodgkin lymphoma. Lab Invest (2009) 1.04
Comparison of atherosclerotic indicators between cardio ankle vascular index and brachial ankle pulse wave velocity. Angiology (2008) 1.04
Activation of KIF4A as a prognostic biomarker and therapeutic target for lung cancer. Clin Cancer Res (2007) 1.04
Associations between small dense LDL, HDL subfractions (HDL2, HDL3) and risk of atherosclerosis in Japanese-Americans. J Atheroscler Thromb (2011) 1.04
MUC5B promoter polymorphism in Japanese patients with idiopathic pulmonary fibrosis. Respirology (2015) 1.04
Intra-airway administration of small interfering RNA targeting plasminogen activator inhibitor-1 attenuates allergic asthma in mice. Am J Physiol Lung Cell Mol Physiol (2011) 1.03